Company news
Nuwellis, Inc. news in 2025
Nuwellis, Inc.'s news releases, calls and decks from 2025, newest first.
Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings
December 9, 2025
Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.
December 4, 2025
Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum
November 12, 2025
Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology
November 10, 2025
Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025
October 23, 2025
Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®
September 30, 2025
Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration
September 18, 2025
Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment
September 17, 2025
Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio
September 9, 2025
Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management
September 4, 2025
Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter
August 21, 2025
Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company
August 19, 2025
Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
August 15, 2025
Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights
August 14, 2025
Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus
August 7, 2025
Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025
August 6, 2025
Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code
August 5, 2025
Nuwellis Stockholders Approve All Proposals at Special Meeting
August 4, 2025
Nuwellis Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
July 23, 2025
Nuwellis Regains Compliance with Nasdaq Listing Requirements
July 23, 2025
Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025
July 22, 2025
Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care
July 17, 2025
Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation
July 15, 2025
Nuwellis Appoints John Erb as Chief Executive Officer
July 2, 2025
Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option
June 10, 2025
Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering
June 9, 2025
Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights
May 13, 2025
Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency
May 11, 2025
Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems
May 8, 2025
Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision
April 24, 2025
Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025
April 22, 2025
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025
Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO
February 24, 2025
JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis
February 20, 2025
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
February 18, 2025
Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy
January 12, 2025
Calls in 2025
Decks in 2025
- Investor Presentation (December 2025)
Investor deck · 28 slides · December 2025
- Q1 2025 Earnings Presentation
Earnings · 25 slides · May 13, 2025
- Investor Presentation (April 2025)
Investor deck · 25 slides · Apr 3, 2025